Evidence Prime: Laser AI
What its stage means
An agency or the FedRAMP program authorized it. Agencies can reuse that authorization.
The provider's description
LASER is a system automating the development of Living Systematic Reviews using natural language processing (NLP) and artificial intelligence techniques, which synthesizes available knowledge about a given health problem continuously and with minimal human involvement. As a result, LASER speeds up the process of literature reviews, decreases its costs, and improves the quality of the reviews allowing overworked human specialists to focus on the essential elements offloading much of the repetitive tasks to the AI-enabled system. LASER also provides a human-centric user interface, enabling smooth interaction with suggestions provided by the AI.
LASER supports classical systematic reviews as well as enables quick verification of the quality of the reviews by the regulators and the sponsors, makes it possible to perform a larger number of reviews for personalized medicine or the creation of high-quality rapid assessments in the face of epidemics or ecological disasters.
LASER is built with larger organizations in mind, providing a high level of security as well as enterprise-grade management of projects, teams, roles, shared dictionaries, and customizable workflow processes. LASER helps with the following steps of literature reviews: creation of the review protocol, construction and execution of a search strategy, T&A screening, screening of full texts, data extraction, quality assessment, export of data to meta-analysis tools.
What FedXchange has recorded
No change since FedXchange began following it on April 14, 2026. Each change of stage, impact level, or number of authorizations appears here.